Home › Glioma
Pag-aaral pangklinika para sa Glioma na nagre-recruit sa U.S.
118 pag-aaral para sa Glioma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY25 pag-aaral
- Houston, TX23 pag-aaral
- Boston, MA20 pag-aaral
- Washington, DC19 pag-aaral
- Philadelphia, PA16 pag-aaral
- Miami, FL15 pag-aaral
- Columbus, OH15 pag-aaral
- San Francisco, CA14 pag-aaral
- Chicago, IL13 pag-aaral
- Durham, NC12 pag-aaral
- Seattle, WA11 pag-aaral
- Aurora, CO10 pag-aaral
- St. Louis, MO10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Cincinnati, OH9 pag-aaral
- Rochester, MN9 pag-aaral
- Edison, NJ8 pag-aaral
- Queens, NY7 pag-aaral
- Atlanta, GA7 pag-aaral
- Nashville, TN6 pag-aaral
- Dallas, TX6 pag-aaral
- Jacksonville, FL6 pag-aaral
- San Diego, CA6 pag-aaral
- Birmingham, AL6 pag-aaral
- Baltimore, MD6 pag-aaral
- Omaha, NE6 pag-aaral
- Orange, CA6 pag-aaral
- San Antonio, TX5 pag-aaral
- New Rochelle, NY5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Cleveland, OH5 pag-aaral
- Tampa, FL4 pag-aaral
- Pittsburgh, PA4 pag-aaral
- Arlington, VA4 pag-aaral
- Indianapolis, IN4 pag-aaral
- Greenburgh, NY4 pag-aaral
- East Norwalk, CT4 pag-aaral
- Staten Island, NY4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Detroit, MI4 pag-aaral
Ayos sa estado
- Alabama6 pag-aaral
- Arizona8 pag-aaral
- California25 pag-aaral
- Colorado11 pag-aaral
- Connecticut6 pag-aaral
- District of Columbia14 pag-aaral
- Florida23 pag-aaral
- Georgia7 pag-aaral
- Illinois13 pag-aaral
- Indiana4 pag-aaral
- Iowa3 pag-aaral
- Maryland11 pag-aaral
- Massachusetts20 pag-aaral
- Michigan8 pag-aaral
- Minnesota13 pag-aaral
- Missouri11 pag-aaral
- Nebraska6 pag-aaral
- New Jersey10 pag-aaral
- New York28 pag-aaral
- North Carolina16 pag-aaral
- Ohio18 pag-aaral
- Pennsylvania19 pag-aaral
- Tennessee8 pag-aaral
- Texas26 pag-aaral
- Utah4 pag-aaral
- Virginia5 pag-aaral
- Washington11 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05030298A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Nagre-recruitPhase 1/2
12 Months – 21 Years · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05099003Language Network Prehab Via fMRI Neurofeedback
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07488780Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07416188Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Nagre-recruitPhase 1/2
Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03896568Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
Nagre-recruitMaagang Phase 1
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05555550Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT04977375ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Nagre-recruitPhase 1
Edad 5 hanggang 18 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06357377Development of MRF for Characterization of Brain Tumors After Radiotherapy
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06101069MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04373720Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04771806A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05698524NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Nagre-recruitPhase 1
Edad 3 hanggang 25 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07664176Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Nagre-recruitPhase 1
36 Months · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07076498Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388A Study of Mirdametinib in People With Central Nervous System Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07539441Assessing Brain Metabolism Using MRS With Deuterated Glucose
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06594315Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT05489783SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Nagre-recruitPhase 1/2
Edad 15 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05588141Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.